Dr. Samuel Ray Denmeade M.D.
Oncologist | Medical Oncology
1800 Orleans St Baltimore MD, 21287About
Dr. Samuel Denmeade is an oncologist practicing in Baltimore, MD. Dr. Denmeade specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Denmeade manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
Columbia Univ Coll of Physicians And Surgeons, New York Ny 1989
Columbia University College of Physicians and Surgeons 1989
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Complete androgen blockade for prostate cancer: what went wrong?
- Delayed micromolar elevation in intracellular calcium precedes induction of apoptosis in thapsigargin-treated breast cancer cells.
- In vivo activity of a PSA-activated doxorubicin prodrug against PSA-producing human prostate cancer xenografts.
- Expression of prostate-specific membrane antigen in transitional cell carcinoma of the bladder: prognostic value?
- CEP-701 and CEP-751 inhibit constitutively activated RET tyrosine kinase activity and block medullary thyroid carcinoma cell growth.
- Anti-tumor effect of combination therapy with intratumoral controlled-release paclitaxel (PACLIMER microspheres) and radiation.
- Use of methotrexate-based peptide substrates to characterize the substrate specificity of prostate-specific membrane antigen (PSMA).
- Screening a combinatorial peptide library to develop a human glandular kallikrein 2-activated prodrug as targeted therapy for prostate cancer.
- A combinatorial approach to the selective capture of circulating malignant
- Activity of irinotecan and the tyrosine kinase inhibitor CEP-751 in medullary thyroid cancer.
- Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug.
- Comparative study of PSMA expression in the prostate of mouse, dog, monkey, and human.
- Synthesis and screening of a random dimeric peptide library using the one-bead-one-dimer combinatorial approach.
- Phase II evaluation of docetaxel plus exisulind in patients with androgen independent prostate carcinoma.
- A dimeric peptide that binds selectively to prostate-specific membrane antigen and inhibits its enzymatic activity.
Clinical Trials
Treatments
- Prostate Cancer
- Kidney Cancer
- Testicular Cancer
Dr. Samuel Ray Denmeade M.D.'s Practice location
Johns Hopkins Medicine
1800 Orleans St -Baltimore, MD 21287Get Direction
Dr. Samuel Ray Denmeade M.D.'s reviews
Write ReviewRecommended Articles
![]()
Colon CancerWhat is colon cancer?Colon cancer is cancer of the large intestine, also known as the colon. If the last segment of the colon, the rectum, has a cancerous growth, it is known as rectal carcinoma. These two conditions are collectively referred to as colorectal cancer.Carcinoma of the colon is the...
- What are the Side Effects of Chemotherapy?
Chemotherapy is a treatment method which makes use of certain drugs in treating cancer. It plays a number of roles in the body as part of the treatment mechanism. This may include killing cancer cells, reducing their rate of spreading or shrinking the tumors to reduce the recurrence and...
![]()
BRCA Gene Risk Status Identified for Ovarian CancerIt is well-known in the medical community that a specific genetic mutation can increase your risk of getting ovarian cancer and breast cancer. These genes are commonly known as BRCA1 and BRCA 2. While it is more likely that you’ll get ovarian cancer if you happen to have this genetic abnormality,...
![]()
Cyclist Battles Back from Lymphoma to Make Professional DebutIn October of 2015, 16-year-old Zack Gilmore felt a lump behind his ear after finishing a cycling training session. He went to the doctor to find out what it was and, three days later, he received the dreadful news: a non-Hodgkin’s lymphoma diagnosis. Gilmore began chemotherapy right away at the...
![]()
What Is Squamous Cell Carcinoma?Squamous cell carcinoma is a kind of small-cell lung cancer (SCLC) that constitutes nearly 20 percent of all lung cancers. As the name indicates, the small-cell lung cancers form a smaller variety of lung cells that line surfaces and cavities, and are normally located in the central airways...
![]()
What Are Petechiae?What Are Petechiae?Petechiae can be described as marks or blotches that normally appear on the skin and are tiny, round, and purplish or reddish in color. Petechiae are usually pinpoint-sized. Minor hemorrhage (bleeding that is localized below the skin) is the source of petechiae.Although they...
Nearby Providers
![]()
Dr. Johann Brandes MD, PHD1650 Orleans Street Baltimore MD 21231![]()
Dr. Kit Lu M.D.4940 Eastern Ave Baltimore MD 21224![]()
Dr. Julie Brahmer M.D.401 North Broadway Baltimore Maryland 21231![]()
Dr. Mark Levis M.D.1800 Orleans St Baltimore MD 21287![]()
Dr. Christian Frederick Meyer M.D., PH. D.1650 Orleans St Baltimore MD 21287![]()
Dr. Ivan Marques Borrello M.D.1650 ORLEANS ST BALTIMORE MD 21263
Nearest Hospitals
JOHNS HOPKINS HOSPITAL, THEl
600 NORTH WOLFE STREET BALTIMORE MD 21287KENNEDY KREIGER INSTITUTEl
707 NORTH BROADWAY BALTIMORE MD 21205